ICLR

ICON Public Limited Company NASDAQ

Healthcare ·Medical - Diagnostics & Research ·IE · iconplc.com

$121.32

Mkt Cap $9.3B

52w Low $66.57 37.9% of range 52w High $211.00

50d MA $107.22 200d MA $156.06

P/E (TTM) 11.8x

EV/EBITDA 13.0x

P/B 1.0x

Debt/Equity 0.4x

ROE 8.5%

P/FCF 15.5x

RSI (14) —

ATR (14) —

Beta 1.28

50d MA $107.22

200d MA $156.06

Avg Volume 2.0M

About

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical stud…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	AMC	3.19	3.28	+2.8%	116.17	-0.9%	+1.9%	-2.9%	-3.6%	-2.2%	—	—
Oct 22, 2025	AMC	3.28	3.31	+0.9%	192.60	-1.9%	-6.5%	-7.5%	-5.5%	-7.7%	-13.8%	—
Jul 23, 2025	AMC	3.19	3.26	+2.2%	167.89	+20.3%	+16.2%	+11.4%	+13.0%	+10.3%	+8.1%	—
Apr 30, 2025	AMC	3.11	3.19	+2.6%	151.44	-5.8%	-4.1%	-5.6%	-5.6%	-10.8%	-8.3%	—
Feb 19, 2025	AMC	3.41	3.43	+0.6%	191.32	+1.9%	+5.5%	+5.3%	+4.1%	+3.2%	+2.6%	—
Oct 23, 2024	AMC	3.85	3.35	-13.0%	280.76	-14.3%	-21.0%	-21.5%	-17.9%	-17.2%	-18.8%	—
Jul 24, 2024	AMC	3.68	3.75	+1.9%	331.77	-6.6%	-5.6%	-2.5%	-0.7%	-0.4%	-1.0%	—
Apr 24, 2024	AMC	3.41	3.47	+1.8%	309.44	+0.9%	-3.0%	-0.4%	-1.7%	-3.7%	-2.5%	—
Feb 21, 2024	AMC	3.44	3.46	+0.6%	284.70	+5.9%	+10.1%	+10.4%	+12.0%	+13.3%	+13.6%	—
Oct 25, 2023	AMC	3.28	3.30	+0.6%	225.28	+5.5%	+6.8%	+4.5%	+5.7%	+8.3%	+11.0%	—
Jul 26, 2023	AMC	3.08	3.11	+1.0%	253.10	-3.9%	-4.5%	-0.4%	-0.7%	-1.5%	-0.6%	—
Apr 26, 2023	AMC	2.88	2.90	+0.7%	200.88	+0.8%	-5.1%	-4.1%	-2.7%	-6.5%	-7.5%	—
Feb 22, 2023	AMC	3.06	3.13	+2.3%	221.71	+2.8%	+0.6%	+0.8%	+0.6%	+1.8%	+2.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 26	BMO Capital	Upgrade	Market Perform → Outperform	—	$99.99	$101.63	+1.6%	+3.1%	+2.1%	+5.1%	+10.7%	+11.4%
Mar 11	Citigroup	Maintains	Neutral → Neutral	—	$106.62	$107.12	+0.5%	-1.2%	-8.6%	-7.8%	-8.5%	-5.7%
Mar 9	Barclays	Maintains	Equal Weight → Equal Weight	—	$107.20	$105.77	-1.3%	+2.6%	-0.5%	-1.7%	-9.1%	-8.3%
Feb 23	Jefferies	Upgrade	Hold → Buy	—	$99.70	$100.68	+1.0%	+5.0%	+4.4%	+1.3%	+6.4%	+8.5%
Feb 18	TD Cowen	Upgrade	Hold → Buy	—	$88.62	$89.26	+0.7%	+8.9%	+11.0%	+12.5%	+18.1%	+17.5%
Jan 22	TD Cowen	Maintains	Hold → Hold	—	$184.87	$187.95	+1.7%	+1.0%	+1.0%	+1.4%	+1.7%	+0.8%
Jan 8	Truist	Downgrade	Buy → Hold	—	$202.92	$179.07	-11.8%	-7.2%	-10.6%	-11.2%	-9.7%	-8.9%
Dec 15	Barclays	Maintains	Equal Weight → Equal Weight	—	$186.58	$184.94	-0.9%	-1.2%	-2.2%	-3.9%	-4.2%	-6.9%
Oct 24	Barclays	Maintains	Equal Weight → Equal Weight	—	$180.00	$179.22	-0.4%	-1.1%	+1.1%	-1.3%	-7.8%	-8.2%
Oct 24	TD Cowen	Maintains	Hold → Hold	—	$180.00	$179.22	-0.4%	-1.1%	+1.1%	-1.3%	-7.8%	-8.2%
Oct 2	Barclays	Maintains	Equal Weight → Equal Weight	—	$192.31	$190.26	-1.1%	+0.3%	+0.8%	-1.0%	-2.9%	-3.0%
Sep 9	Jefferies	Downgrade	Buy → Hold	—	$177.81	$171.08	-3.8%	-5.0%	-7.0%	-1.5%	-1.6%	-4.1%
Sep 3	Rothschild & Co	Upgrade	Neutral → Buy	—	$177.84	$182.05	+2.4%	+1.2%	-0.8%	-1.7%	-0.0%	-5.0%
Sep 2	Baird	Maintains	Outperform → Outperform	—	$177.94	$176.65	-0.7%	-0.1%	+1.2%	-0.9%	-1.7%	-0.1%
Aug 21	Citigroup	Downgrade	Buy → Neutral	—	$180.25	$177.01	-1.8%	-2.5%	-2.5%	-4.7%	-4.7%	-3.5%
Jul 25	Evercore ISI	Maintains	Outperform → Outperform	—	$195.01	$193.41	-0.8%	-4.1%	-2.7%	-5.0%	-6.9%	-13.2%
Jul 25	UBS	Maintains	Buy → Buy	—	$195.01	$193.41	-0.8%	-4.1%	-2.7%	-5.0%	-6.9%	-13.2%
Jul 25	Truist	Maintains	Buy → Buy	—	$195.01	$193.41	-0.8%	-4.1%	-2.7%	-5.0%	-6.9%	-13.2%
Jul 25	Mizuho	Maintains	Outperform → Outperform	—	$195.01	$193.41	-0.8%	-4.1%	-2.7%	-5.0%	-6.9%	-13.2%
Jul 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$195.01	$193.41	-0.8%	-4.1%	-2.7%	-5.0%	-6.9%	-13.2%
Jul 24	Baird	Upgrade	Neutral → Outperform	—	$167.89	$202.04	+20.3%	+16.2%	+11.4%	+13.0%	+10.3%	+8.1%
Jul 9	Evercore ISI	Maintains	Outperform → Outperform	—	$151.58	$152.85	+0.8%	-0.7%	+0.3%	-0.7%	-1.4%	-4.0%
May 15	Mizuho	Maintains	Outperform → Outperform	—	$132.23	$131.41	-0.6%	-1.2%	-0.5%	-1.1%	-0.1%	-4.2%
May 2	Goldman Sachs	Maintains	Neutral → Neutral	—	$145.21	$148.32	+2.1%	-1.5%	-1.5%	-7.0%	-4.4%	-4.6%
May 2	Barclays	Maintains	Equal Weight → Equal Weight	—	$145.21	$148.32	+2.1%	-1.5%	-1.5%	-7.0%	-4.4%	-4.6%
May 2	Baird	Maintains	Neutral → Neutral	—	$145.21	$148.32	+2.1%	-1.5%	-1.5%	-7.0%	-4.4%	-4.6%
Apr 29	JP Morgan	Downgrade	Overweight → Neutral	—	$145.00	$142.89	-1.5%	+3.0%	+4.4%	+0.1%	-1.4%	-1.4%
Apr 14	TD Cowen	Downgrade	Buy → Hold	—	$144.04	$144.54	+0.3%	+1.9%	+0.8%	-0.3%	-3.3%	-4.7%
Apr 10	Barclays	Downgrade	Overweight → Equal Weight	—	$155.49	$148.51	-4.5%	-8.3%	-7.4%	-5.6%	-6.6%	-7.7%
Apr 10	Truist	Maintains	Buy → Buy	—	$155.49	$148.51	-4.5%	-8.3%	-7.4%	-5.6%	-6.6%	-7.7%
Apr 9	Mizuho	Maintains	Outperform → Outperform	—	$142.50	$141.08	-1.0%	+9.1%	+0.1%	+1.1%	+3.0%	+1.9%
Apr 7	Citigroup	Maintains	Buy → Buy	—	$153.72	$149.22	-2.9%	-1.9%	-7.3%	+1.2%	-7.2%	-6.3%
Mar 21	Goldman Sachs	Downgrade	Buy → Neutral	—	$183.96	$177.92	-3.3%	+0.5%	+0.3%	-2.7%	-2.8%	-2.1%
Mar 4	Baird	Maintains	Neutral → Neutral	—	$184.81	$184.71	-0.1%	-0.6%	+0.9%	+0.2%	+0.9%	-1.1%
Feb 21	Barclays	Maintains	Overweight → Overweight	—	$201.84	$204.68	+1.4%	-0.2%	-1.3%	-2.2%	-2.8%	-6.0%
Feb 13	Truist	Maintains	Buy → Buy	—	$186.53	$186.25	-0.2%	-2.1%	-0.2%	+1.1%	+2.6%	+8.2%
Feb 3	JP Morgan	Maintains	Overweight → Overweight	—	$199.08	$194.19	-2.5%	-1.8%	-2.9%	-1.3%	-1.6%	-2.8%
Jan 15	RBC Capital	Maintains	Outperform → Outperform	—	$200.24	$204.19	+2.0%	-0.4%	+1.1%	-1.1%	+2.4%	+1.4%
Jan 14	William Blair	Maintains	Outperform → Outperform	—	$217.99	$199.39	-8.5%	-8.1%	-8.5%	-7.1%	-9.1%	-5.9%
Jan 6	Citigroup	Maintains	Buy → Buy	—	$213.28	$214.11	+0.4%	+1.0%	+4.4%	+2.8%	+2.3%	+2.2%
Dec 18	Truist	Maintains	Buy → Buy	—	$203.26	$203.93	+0.3%	+0.6%	+0.7%	+2.1%	+3.3%	+4.9%
Nov 20	Baird	Maintains	Neutral → Neutral	—	$195.60	$196.67	+0.5%	+4.1%	+8.8%	+9.5%	+10.8%	+8.5%
Nov 19	Leerink Partners	Maintains	Outperform → Outperform	—	$187.22	$186.79	-0.2%	+4.5%	+8.8%	+13.6%	+14.4%	+15.8%
Oct 28	Truist	Maintains	Buy → Buy	—	$220.47	$221.26	+0.4%	+4.5%	+5.4%	+3.4%	+0.7%	-0.0%
Oct 25	Leerink Partners	Maintains	Outperform → Outperform	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%
Oct 25	JP Morgan	Maintains	Overweight → Overweight	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%
Oct 25	TD Cowen	Maintains	Buy → Buy	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%
Oct 25	Goldman Sachs	Maintains	Buy → Buy	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%
Oct 25	Baird	Maintains	Neutral → Neutral	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%
Oct 25	Barclays	Maintains	Overweight → Overweight	—	$221.73	$224.79	+1.4%	-0.6%	+4.0%	+4.8%	+2.8%	+0.2%

Data updated apr 25, 2026 2:52pm · Source: massive.com